产品名称 | NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, hFc-tag |
---|---|
目录号 | NBL-242708 |
别名 | Ephrin-A4/EFNA4; Ephrin-A4; LERK-4; EFNA4; EPLG4; EFL4 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P52798-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242708-100ug | 100ug | Inquire | Inquire | |
NBL-242708-1mg | 1mg | Inquire | Inquire | |
NBL-242708-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, hFc-tag
Catalog#:
NBL-242708
Description:
NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, hFc-tag(Cat#NBL-242708) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu26-Gly171.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 43.1 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
Ephrin-A4/EFNA4; Ephrin-A4; LERK-4; EFNA4; EPLG4; EFL4
Target Information:
Ephrin A4 is one of the ephrin ligand molecules belonging to the tyrosine kinases receptor family. It was originally identified in a T-lymphoma cell line and seen to be expressed in human adult tissue as well as several tumor types. The cytoplasmic pattern of ephrin A4 could identify a subgroup of primary osteosarcoma patients with a high liability for progression, poor prognosis, and inferior response to chemotherapy.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.